NEW
Stock Screener with Intrinsic Value
Regeneron Pharmaceuticals, Inc. (REGN)
Last Price$696.9(5.0%)
Market Cap$75.6B
$13.8B
+5.7% YoY
$4,654.5M
+16.6% YoY
($7,092.5M)
Net Debt to FCF - (2.1x)
$3,377.6M
24.4% margin
REGN Income Statement
REGN Income Statement Overview
Crunching data... Almost there!
REGN Income statement key metrics
Crunching data... Almost there!
REGN Balance Sheet
REGN Balance Sheet Overview
Crunching data... Almost there!
REGN Balance Sheet Metrics
Crunching data... Almost there!
REGN Cash Flow Statement
REGN Cash Flow Statement Overview
Crunching data... Almost there!
REGN Cash Flow Statement key metrics
Crunching data... Almost there!
REGN Financials
Crunching data... Almost there!
FAQ
What is the Regeneron Pharmaceuticals, Inc. (REGN) revenue?
The Regeneron Pharmaceuticals, Inc. (REGN) revenue is $13.1B, reflecting a year-over-year (YoY) growth of +7.8% YoY.
What is the Regeneron Pharmaceuticals, Inc. (REGN) Net Income?
The Regeneron Pharmaceuticals, Inc. (REGN) Net Income is $3,953.6M, showcasing a YoY growth of -8.9% YoY.